Exploring the Potential Role of Upper Abdominal Peritonectomy in Advanced Ovarian Cancer Cytoreductive Surgery Using Explainable Artificial Intelligence

Exploring the Potential Role of Upper Abdominal Peritonectomy in Advanced Ovarian Cancer Cytoreductive Surgery Using Explainable Artificial Intelligence

The Surgical Complexity Score (SCS) has been widely used to describe the surgical effort during advanced stage epithelial ovarian cancer (EOC) cytoreduction. Referring to a variety of multi-visceral resections, it best combines the numbers with the complexity of the sub-procedures. Nevertheless, not...

Full description

Bibliographic Details
Main Authors:	Alexandros Laios, Evangelos Kalampokis, Marios Evangelos Mamalis, Amudha Thangavelu, Richard Hutson, Tim Broadhead, David Nugent, Diederick De Jong
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Series:	Cancers
Subjects:	epithelial ovarian cancer complete cytoreduction upper abdominal peritonectomy machine learning explainable artificial intelligence survival
Online Access:	https://www.mdpi.com/2072-6694/15/22/5386

Similar Items

Explainable Artificial Intelligence for Prediction of Complete Surgical Cytoreduction in Advanced-Stage Epithelial Ovarian Cancer
by: Alexandros Laios, et al.
Published: (2022-04-01)

Explaining the Elusive Nature of a Well-Defined Threshold for Blood Transfusion in Advanced Epithelial Ovarian Cancer Cytoreductive Surgery
by: Alexandros Laios, et al.
Published: (2023-12-01)

Factors Predicting Surgical Effort Using Explainable Artificial Intelligence in Advanced Stage Epithelial Ovarian Cancer
by: Alexandros Laios, et al.
Published: (2022-07-01)

Development of a Novel Intra-Operative Score to Record Diseases’ Anatomic Fingerprints (ANAFI Score) for the Prediction of Complete Cytoreduction in Advanced-Stage Ovarian Cancer by Using Machine Learning and Explainable Artificial Intelligence
by: Alexandros Laios, et al.
Published: (2023-02-01)

The application of pringle manoeuvre, type three liver mobilisation, full thickness diaphragmatic resection with primary closure technique and peritonectomy in the management of advanced ovarian malignancy
by: Sarah Louise Smyth, et al.
Published: (2023-09-01)

Total parietal peritonectomy in primary debulking surgery for advanced ovarian cancer
by: Kota Yokosu, et al.
Published: (2021-08-01)

Risk factors and clinical outcomes in patients undergoing cytoreductive surgery with concomitant ureteric reimplantation
by: Alonso Anais, et al.
Published: (2021-11-01)

Cytoreductive Surgery for Peritoneal Carcinomatosis from Gastric Cancer: Technical Details
by: Thomas Boerner, et al.
Published: (2021-11-01)

Combination therapy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent leiomyomatosis peritonealis disseminata with endometriosis: A case report
by: Xiaoli Xiao, et al.
Published: (2023-09-01)

Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience
by: Francesco Santullo, et al.
Published: (2021-08-01)

Survival and Chemosensitivity in Advanced High Grade Serous Epithelial Ovarian Cancer Patients with and without a BRCA Germline Mutation: More Evidence for Shifting the Paradigm towards Complete Surgical Cytoreduction
by: Diederick De Jong, et al.
Published: (2022-11-01)

The Road to Technical Proficiency in Cytoreductive Surgery for Peritoneal Carcinomatosis: Risk-Adjusted Cumulative Summation Analysis
by: Francesco Santullo, et al.
Published: (2022-05-01)

Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS Score
by: Alexandros Laios, et al.
Published: (2022-11-01)

Predicting complete cytoreduction for advanced ovarian cancer patients using nearest-neighbor models
by: Alexandros Laios, et al.
Published: (2020-09-01)

The Uncertain Benefit of Adjuvant Chemotherapy in Advanced Low-Grade Serous Ovarian Cancer and the Pivotal Role of Surgical Cytoreduction
by: Racheal Louise Johnson, et al.
Published: (2021-12-01)

Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients
by: Warschkow Rene, et al.
Published: (2012-06-01)

Platinum resistant recurrence and early recurrence in a multi-centre cohort of patients undergoing interval cytoreductive surgery for advanced epithelial ovarian cancer
by: Aditi Bhatt, et al.
Published: (2022-09-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

Advances in diffuse malignant peritoneal mesothelioma
by: Tristan D. Yan, et al.
Published: (2011-12-01)

Machine Learning-Based Risk Prediction of Critical Care Unit Admission for Advanced Stage High Grade Serous Ovarian Cancer Patients Undergoing Cytoreductive Surgery: The Leeds-Natal Score
by: Alexandros Laios, et al.
Published: (2021-12-01)

Quaternary and beyond cytoreduction: An updated and expanded analysis
by: Beryl L. Manning-Geist, et al.
Published: (2021-08-01)

Pseudomixoma peritoneal avanzado por adenocarcinoma mucinoso de apéndice
by: José Luis González González, et al.

RoBERTa-Assisted Outcome Prediction in Ovarian Cancer Cytoreductive Surgery Using Operative Notes
by: Alexandros Laios MD, PhD, PostDoc (Ox), et al.
Published: (2023-10-01)

Cirrhosis is not a contraindication to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in highly selected patients
by: Anna Weiss, et al.
Published: (2018-04-01)

Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramifications
by: Diederick de Jong, et al.
Published: (2023-11-01)

An update of peritonectomy procedures used in cytoreductive surgery for peritoneal malignancy
by: Frédéric Mercier, et al.
Published: (2019-01-01)

Clinical Utility of Preoperative Assessment in Ovarian Cancer Cytoreduction
by: Pratistha Koirala, et al.
Published: (2020-08-01)

New Paradigms for Cytoreductive Nephrectomy
by: Benjamin J. Lichtbroun, et al.
Published: (2022-05-01)

Cytoreductive surgery for men with metastatic prostate cancer
by: Nikolas Katelaris, et al.
Published: (2016-09-01)

Impact of tumor cytoreduction in metastatic prostate cancer
by: Sow Y, et al.
Published: (2019-05-01)

Cytoreductive nephrectomy for metastatic renal cell carcinoma
by: Rajendra B Nerli
Published: (2013-01-01)

Factors Affecting Early Morbidity and Mortality in Patients with Complete Cytoreduction for Peritoneal Carcinomatosis
by: Erdal Bostanci, et al.
Published: (2022-09-01)

Secondary surgical cytoreduction needs to be assessed taking into account surgical technique, completeness of cytoreduction, and extent of disease
by: Juan José Segura-Sampedro, et al.
Published: (2020-05-01)

Significance of laparoscopic cytoreductive surgery for appendiceal pseudomyxoma peritonei with limited disease and low tumor burden
by: Chong Wang, et al.
Published: (2023-03-01)

The role of cytoreduction surgery in advanced ovarian cancer (review)
by: R K Tandelov, et al.
Published: (2018-03-01)

The Future of AI in Ovarian Cancer Research: The Large Language Models Perspective
by: Alexandros Laios, et al.
Published: (2023-08-01)

Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
by: Maria Consuelo Pintado, et al.
Published: (2023-06-01)

Chemokine Ligand 5 to Predict Optimal Cytoreduction in Ovarian Cancer
by: Hidayat YM, et al.
Published: (2020-11-01)

Two-step cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei with high peritoneal carcinomatosis index
by: Bertrand Trilling, et al.
Published: (2021-02-01)

Predictors of Recurrence of Peritoneal Carcinomatosis among Patients with Colorectal Cancer Following Cytoreductive Surgery alone versus Cytoreductive Surgery Plus HIPEC
by: Waheed Yousry Gareer, et al.
Published: (2022-06-01)